Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 16, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Oral and nasal disinfection, a simple method with the application of commonly used antiseptic agents is frequently performed in the otolaryngology and dental practice. The ability to deactivate viral particles with a good safety profile may be an important benefit in the control of viral proliferation and shedding. Actually, multiple anti-septic agents demonstrated virucidal properties against SARS-CoV-2 in several in vitro studies. Among these, Povidone-Iodine (PVP-I), common usage in otolaryngology operation and topical therapy, showed high virucidal properties (0.45% PVP-I, throat spray,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age older than 20 years of age
- • 2. admission with a confirmed positive test for SARS-CoV-2 infection by reverse transcription polymerase chain reaction (RT- PCR)
- • 3. disease onset (start of COVID-19 symptom and PCR test) for ≤ 120 hours
- • 4. available informed consent of this study.
- • 5. Full COVID-19 vaccination(at least after 2nd dose of TFDA-approved vaccine 14 days)
- Exclusion Criteria:
- • 1. receiving oxygen supply before intervention
- • 2. known intolerance/allergy to the study drugs
- • 3. pregnancy
- • 4. sinus/oral operation within 30 days of the beginning of the study
- • 5. using intranasal medication before randomization
- • 6. no available informed consent
- • 7. inability to self-care or reply to questionnaire
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Te-Huei Yeh, MD-PhD
Principal Investigator
National Taiwan University Hospital, Department of Otolaryngology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials